These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18035965)

  • 1. Recent advances, trends and economic considerations in the risk assessment, prevention and treatment of postoperative nausea and vomiting.
    Kranke P; Schuster F; Eberhart LH
    Expert Opin Pharmacother; 2007 Dec; 8(18):3217-35. PubMed ID: 18035965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palonosetron and aprepitant for the prevention of postoperative nausea and vomiting in patients indicated for laparoscopic gynaecologic surgery: a double-blind randomised trial.
    Moon HY; Baek CW; Choi GJ; Shin HY; Kang H; Jung YH; Woo YC; Kim JY; Park SG
    BMC Anesthesiol; 2014; 14():68. PubMed ID: 25165427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting serotonin antagonist (Palonosetron) and the NK-1 receptor antagonists: does extended duration of action improve efficacy?
    Melton MS; Nielsen KC; Tucker M; Klein SM; Gan TJ
    Anesthesiol Clin; 2014 Jun; 32(2):505-16. PubMed ID: 24882134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurokinin-1 and novel serotonin antagonists for postoperative and postdischarge nausea and vomiting.
    George E; Hornuss C; Apfel CC
    Curr Opin Anaesthesiol; 2010 Dec; 23(6):714-21. PubMed ID: 20871394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
    Singh PM; Borle A; Gouda D; Makkar JK; Arora MK; Trikha A; Sinha A; Goudra B
    J Clin Anesth; 2016 Nov; 34():459-82. PubMed ID: 27687434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.
    Gao HF; Liang Y; Zhou NN; Zhang DS; Wu HY
    Intern Med J; 2013 Jan; 43(1):73-6. PubMed ID: 22141732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postoperative nausea and vomiting--what's new in anti-emetic pharmacotherapy?].
    Wallenborn J; Eberhart LH; Kranke P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Apr; 44(4):296-304; quiz 305. PubMed ID: 19367534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Prophylactic Antiemetic Efficacy of Aprepitant Plus Palonosetron Versus Aprepitant Plus Ramosetron in Patients at High Risk for Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A Prospective Randomized-controlled Trial.
    Choi EK; Kim DG; Jeon Y
    Surg Laparosc Endosc Percutan Tech; 2016 Oct; 26(5):354-357. PubMed ID: 27636144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double blind study to evaluate efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of postoperative and postdischarge nausea and vomiting in subjects undergoing laparoscopic surgeries with high emetogenic risk.
    Blitz JD; Haile M; Kline R; Franco L; Didehvar S; Pachter HL; Newman E; Bekker A
    Am J Ther; 2012 Sep; 19(5):324-9. PubMed ID: 21519222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of postdischarge nausea and vomiting after ambulatory surgery.
    Melton MS; Klein SM; Gan TJ
    Curr Opin Anaesthesiol; 2011 Dec; 24(6):612-9. PubMed ID: 21934496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacological overview of aprepitant for the prevention of postoperative nausea and vomiting.
    Padilla A; Habib AS
    Expert Rev Clin Pharmacol; 2023; 16(6):491-505. PubMed ID: 37128935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiemetic control: toward a new standard of care for emetogenic chemotherapy.
    Navari RM
    Expert Opin Pharmacother; 2009 Mar; 10(4):629-44. PubMed ID: 19284365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical treatment of chemotherapy-induced nausea and vomiting].
    Herrstedt J
    Ugeskr Laeger; 2007 Feb; 169(9):799-805. PubMed ID: 17355844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing antiemetic therapy in multiple-day and multiple cycles of chemotherapy.
    Ellebaek E; Herrstedt J
    Curr Opin Support Palliat Care; 2008 Mar; 2(1):28-34. PubMed ID: 18685391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting.
    Board T; Board R
    AORN J; 2006 Jan; 83(1):209-16, 219-20. PubMed ID: 16528908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of palonosetron with palonosetron-dexamethasone combination for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.
    Bala I; Bharti N; Murugesan S; Gupta R
    Minerva Anestesiol; 2014 Jul; 80(7):779-84. PubMed ID: 24280811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.
    Kimura H; Yamamoto N; Shirai T; Nishida H; Hayashi K; Tanzawa Y; Takeuchi A; Igarashi K; Inatani H; Shimozaki S; Kato T; Aoki Y; Higuchi T; Tsuchiya H
    Cancer Med; 2015 Mar; 4(3):333-41. PubMed ID: 25533447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of 5-HT(3) RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting.
    Schwartzberg L; Jackson J; Jain G; Balu S; Buchner D
    Expert Rev Pharmacoecon Outcomes Res; 2011 Aug; 11(4):481-8. PubMed ID: 21711119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
    Navari RM
    J Support Oncol; 2003; 1(2):89-103. PubMed ID: 15352652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting: A Network Meta-Analysis.
    Zhang Y; Yang Y; Zhang Z; Fang W; Kang S; Luo Y; Sheng J; Zhan J; Hong S; Huang Y; Zhou N; Zhao H; Zhang L
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27795228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.